Structural insights into Xanthomonas campestris pv. campestris NAD
Journal
Communications biology
ISSN: 2399-3642
Titre abrégé: Commun Biol
Pays: England
ID NLM: 101719179
Informations de publication
Date de publication:
01 Mar 2024
01 Mar 2024
Historique:
received:
09
01
2024
accepted:
15
02
2024
medline:
2
3
2024
pubmed:
2
3
2024
entrez:
1
3
2024
Statut:
epublish
Résumé
Nicotinamide phosphoribosyltransferase (NAMPT) plays an important role in the biosynthesis of nicotinamide adenine dinucleotide (NAD
Identifiants
pubmed: 38429435
doi: 10.1038/s42003-024-05921-3
pii: 10.1038/s42003-024-05921-3
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
255Subventions
Organisme : National Natural Science Foundation of China (National Science Foundation of China)
ID : 32160064
Informations de copyright
© 2024. The Author(s).
Références
Xiao, W., Wang, R.-S., Handy, D. E., Loscalzo, J. J. A. & Signaling, R. NAD (H) and NADP (H) redox couples and cellular energy metabolism. Antioxid. Redox Signal 28, 251–272 (2018).
pmcid: 5737637
doi: 10.1089/ars.2017.7216
Kochnolte, F., Haag, F., Guse, A. H., Lund, F. E. & Ziegler, M. Emerging Roles of NAD+ and its metabolites in cell signaling. Sci. Signal 2, mr1 (2009).
Fang, E. F. et al. NAD+ Replenishment Improves Lifespan and Healthspan in Ataxia Telangiectasia Models via Mitophagy and DNA Repair. Cell Metab. 24, 566–581 (2016).
pmcid: 5777858
doi: 10.1016/j.cmet.2016.09.004
Carbone, F. et al. Regulation and function of extracellular nicotinamide phosphoribosyltransferase/visfatin. Compr. Physiol. 7, 603–621 (2017).
doi: 10.1002/cphy.c160029
Ryall, J. G. et al. The NAD(+)-dependent SIRT1 deacetylase translates a metabolic switch into regulatory epigenetics in skeletal muscle stem cells. Cell Stem Cell 16, 171–183 (2015).
pmcid: 4320668
doi: 10.1016/j.stem.2014.12.004
Hou, Y. et al. NAD+ supplementation normalizes key Alzheimer’s features and DNA damage responses in a new AD mouse model with introduced DNA repair deficiency. Proc. Natl Acad. Sci. USA 115, E1876–E1885 (2018).
pmcid: 5828618
doi: 10.1073/pnas.1718819115
Yoshida, M. et al. Extracellular vesicle-contained eNAMPT delays aging and extends lifespan in mice. Cell Metab. 30, 329–342 (2019).
Chowdhry, S. et al. NAD metabolic dependency in cancer is shaped by gene amplification and enhancer remodelling. Nature 569, 570–575 (2019).
pmcid: 7138021
doi: 10.1038/s41586-019-1150-2
Verdin, E. NAD
doi: 10.1126/science.aac4854
Gazzaniga, F. S., Stebbins, R., Chang, S. Z., Mcpeek, M. A. & Brenner, C. Microbial NAD metabolism: lessons from comparative genomics. Microbiol. Mol. Biol. Rev. 73, 529–541 (2009).
pmcid: 2738131
doi: 10.1128/MMBR.00042-08
Garten, A., Petzold, S., Körner, A., Imai, S. & Kiess, W. Nampt: linking NAD biology, metabolism and cancer. Trends Endocrinol. Metab. 20, 130–138 (2009).
doi: 10.1016/j.tem.2008.10.004
Revollo, J. R., Grimm, A. A. & Imai, S. The NAD biosynthesis pathway mediated by nicotinamide phosphoribosyltransferase regulates Sir2 activity in mammalian cells. J. Biol. Chem. 279, 50754–50763 (2004).
doi: 10.1074/jbc.M408388200
Bockwoldt, M. et al. Identification of evolutionary and kinetic drivers of NAD-dependent signaling. Proc. Natl Acad. Sci. USA 116, 15957–15966 (2019).
pmcid: 6689970
doi: 10.1073/pnas.1902346116
Shats, I. et al. Bacteria boost mammalian host NAD metabolism by engaging the deamidated biosynthesis pathway. Cell Metab. 31, 564 (2020).
pmcid: 7194078
doi: 10.1016/j.cmet.2020.02.001
Gardell, S. J. et al. Boosting NAD(+) with a small molecule that activates NAMPT. Nat. Commun. 10, 3241 (2019).
pmcid: 6642140
doi: 10.1038/s41467-019-11078-z
Galli, U. et al. Medicinal chemistry of nicotinamide phosphoribosyltransferase (NAMPT) inhibitors. J. Med. Chem. 56, 6279–6296 (2013).
doi: 10.1021/jm4001049
Desautels, D. N., Bourrier, M., Peltier, C., Banerji, V. & Banerji, S. O. Effect of FK866, NAMPT inhibitor, on small cell lung cancer cell lines. J. Clin. Oncol. 33, e18562–e18562 (2015).
doi: 10.1200/jco.2015.33.15_suppl.e18562
Grozio, A. et al. CD73 protein as a source of extracellular precursors for sustained NAD+ biosynthesis in FK866-treated tumor cells. J. Biol. Chem. 288, 25938–25949 (2013).
pmcid: 3764798
doi: 10.1074/jbc.M113.470435
Wang, W. et al. Structural basis for resistance to diverse classes of NAMPT inhibitors. PLoS ONE 9, e109366 (2014).
pmcid: 4186856
doi: 10.1371/journal.pone.0109366
Lima, W. C., Varani, A. M. & Menck, C. F. M. NAD biosynthesis evolution in bacteria: lateral gene transfer of kynurenine pathway in Xanthomonadales and Flavobacteriales. Mol. Biol. Evol. 26, 399–406 (2008).
doi: 10.1093/molbev/msn261
Huang, N. et al. Bifunctional NMN adenylyltransferase/ADP-ribose pyrophosphatase: structure and function in bacterial NAD metabolism. Structure 16, 196–209 (2008).
pmcid: 2258087
doi: 10.1016/j.str.2007.11.017
Foster, J. W., Kinney, D. M. & Moat, A. G. Pyridine nucleotide cycle of Salmonella typhimurium: isolation and characterization of pncA, pncB, and pncC mutants and utilization of exogenous nicotinamide adenine dinucleotide. J. Bacteriol. 137, 1165–1175 (1979).
pmcid: 218297
doi: 10.1128/jb.137.3.1165-1175.1979
Galeazzi, L. et al. Identification of nicotinamide mononucleotide deamidase of the bacterial pyridine nucleotide cycle reveals a novel broadly conserved amidohydrolase family. J. Biol. Chem. 286, 40365–40375 (2011).
pmcid: 3220592
doi: 10.1074/jbc.M111.275818
Sorci, L. et al. Genomics-driven reconstruction of acinetobacter NAD metabolism: insights for antibacterial target selection. J. Biol. Chem. 285, 39490–39499 (2010).
pmcid: 2998121
doi: 10.1074/jbc.M110.185629
Amici, A. et al. Synthesis and degradation of adenosine 5′-tetraphosphate by nicotinamide and nicotinate phosphoribosyltransferases. Cell Chem. Biol. 24, 553–564 (2017).
doi: 10.1016/j.chembiol.2017.03.010
Gerdes, S. Y. et al. Comparative genomics of NAD biosynthesis in cyanobacteria. J. Bacteriol. 188, 3012–3023 (2006).
pmcid: 1446974
doi: 10.1128/JB.188.8.3012-3023.2006
Marletta, A. S. et al. Crystal structure of human nicotinic acid phosphoribosyltransferase. FEBS Open Bio 5, 419–428 (2015).
pmcid: 4442680
doi: 10.1016/j.fob.2015.05.002
Chappie, J. S. et al. The structure of a eukaryotic nicotinic acid phosphoribosyltransferase reveals structural heterogeneity among type II PRTases. Structure 13, 1385–1396 (2005).
doi: 10.1016/j.str.2005.05.016
Shin, D. H. et al. Crystal structure of a nicotinate phosphoribosyltransferase from Thermoplasma acidophilum. J. Biol. Chem. 280, 18326–18335 (2005).
doi: 10.1074/jbc.M501622200
Zhang, R. Y. et al. A fluorometric assay for high-throughput screening targeting nicotinamide phosphoribosyltransferase. Anal. Biochem. 412, 18–25 (2011).
doi: 10.1016/j.ab.2010.12.035
Burgos, E. S. & Schramm, V. L. Weak coupling of ATP hydrolysis to the chemical equilibrium of human nicotinamide phosphoribosyltransferase. Biochemistry 47, 11086–11096 (2008).
doi: 10.1021/bi801198m
Brown, A. Analysis of cooperativity by isothermal titration calorimetry. Int. J. Mol. Sci. 10, 3457–3477 (2009).
pmcid: 2812830
doi: 10.3390/ijms10083457
MicroCal PEAQ-ITC Analysis Software User Manual (Malvern Instruments Ltd., 2015).
Hasmann, M. & Schemainda, I. FK866, a highly specific noncompetitive inhibitor of nicotinamide phosphoribosyltransferase, represents a novel mechanism for induction of tumor cell apoptosis. Cancer Res. 63, 7436–7442 (2003).
Khan, J. A., Tao, X. & Tong, L. Molecular basis for the inhibition of human NMPRTase, a novel target for anticancer agents. Nat. Struct. Mol. Biol. 13, 582–588 (2006).
doi: 10.1038/nsmb1105
Burgos, E. S., Ho, M.-C., Almo, S. C. & Schramm, V. L. A phosphoenzyme mimic, overlapping catalytic sites and reaction coordinate motion for human NAMPT. Proc. Natl Acad. Sci. USA 106, 13748–13753 (2009).
pmcid: 2728965
doi: 10.1073/pnas.0903898106
Cao, H., Pietrak, B. L. & Grubmeyer, C. Quinolinate phosphoribosyltransferase: kinetic mechanism for a type II PRTase. Biochemistry 41, 3520–3528 (2002).
doi: 10.1021/bi012148g
Malik, S. S., Patterson, D. N., Ncube, Z. & Toth, E. A. The crystal structure of human quinolinic acid phosphoribosyltransferase in complex with its inhibitor phthalic acid. Proteins: Struct., Funct., Bioinforma. 82, 405–414 (2014).
doi: 10.1002/prot.24406
Youn, H. S. et al. Crystal structure of Sus scrofa quinolinate phosphoribosyltransferase in complex with nicotinate mononucleotide. PLoS ONE 8, e62027 (2013).
pmcid: 3633916
doi: 10.1371/journal.pone.0062027
Luccio, E. D. & Wilson, D. K. Comprehensive X-ray structural studies of the quinolinate phosphoribosyl transferase (BNA6) from Saccharomyces cerevisiae. Biochemistry 47, 4039–4050 (2008).
doi: 10.1021/bi7020475
Kim, M. K., Im, Y. J., Lee, J. H. & Eom, S. H. Crystal structure of quinolinic acid phosphoribosyltransferase from Helicobacter pylori. Proteins 63, 252–255 (2006).
doi: 10.1002/prot.20834
Booth, W. T. et al. Streptococcus pyogenes quinolinate-salvage pathway-structural and functional studies of quinolinate phosphoribosyl transferase and NH3 -dependent NAD+ synthetase. FEBS J. 284, 2425–2441 (2017).
pmcid: 5551413
doi: 10.1111/febs.14136
Liu, H. et al. Structural and kinetic characterization of quinolinate phosphoribosyltransferase (hQPRTase) from homo sapiens. J. Mol. Biol. 373, 755–763 (2007).
pmcid: 3326535
doi: 10.1016/j.jmb.2007.08.043
Schwarzenbacher, R. et al. Crystal structure of a type II quinolic acid phosphoribosyltransferase (TM1645) from Thermotoga maritima at 2.50 A resolution. Proteins 55, 768–771 (2004).
doi: 10.1002/prot.20029
Sharma, V., Grubmeyer, C. & Sacchettini, J. C. Crystal structure of quinolinic acid phosphoribosyltransferase from Mmycobacterium tuberculosis: a potential TB drug target. Structure 6, 1587–1599 (1998).
doi: 10.1016/S0969-2126(98)00156-7
Eads, J. C., Ozturk, D., Wexler, T. B., Grubmeyer, C. & Sacchettini, J. C. A new function for a common fold: the crystal structure of quinolinic acid phosphoribosyltransferase. Structure 5, 47–58 (1997).
doi: 10.1016/S0969-2126(97)00165-2
Galli, U. et al. Recent advances in NAMPT inhibitors: a novel immunotherapic strategy. Front. Pharm. 11, 656 (2020).
doi: 10.3389/fphar.2020.00656
Zhang, S. L. et al. Crystal structure-based comparison of two NAMPT inhibitors. Acta Pharmacologica Sin. 39, 294–301 (2018).
doi: 10.1038/aps.2017.80
Wei, Y., Xiang, H. & Zhang, W. Review of various NAMPT inhibitors for the treatment of cancer. Front. Pharm. 13, 970553 (2022).
doi: 10.3389/fphar.2022.970553
Yao, H. et al. Discovery of small-molecule activators of nicotinamide phosphoribosyltransferase (NAMPT) and their preclinical neuroprotective activity. Cell Res. 32, 1–15 (2022).
doi: 10.1038/s41422-022-00651-9
Xu, L. et al. Average gene length is highly conserved in prokaryotes and eukaryotes and diverges only between the two kingdoms. Mol. Biol. Evol. 23, 1107–1108 (2006).
doi: 10.1093/molbev/msk019
Scopes, R. K. Longer is better—random elongation mutagenesis. Nat. Biotechnol. 17, 21 (1999). -21.
doi: 10.1038/5190
André, I., Strauss, C. E. M., Kaplan, D. B., Bradley, P. & Baker, D. Emergence of symmetry in homooligomeric biological assemblies. Proc. Natl Acad. Sci. USA 105, 16148–16152 (2008).
pmcid: 2570982
doi: 10.1073/pnas.0807576105
Marianayagam, N. J., Sunde, M. & Matthews, J. M. The power of two: protein dimerization in biology. Trends Biochem. Sci. 29, 618–625 (2004).
doi: 10.1016/j.tibs.2004.09.006
Larsen, T. A., Olson, A. J. & Goodsell, D. S. Morphology of protein–protein interfaces. Structure 6, 421–427 (1998).
doi: 10.1016/S0969-2126(98)00044-6
Fisher, D. J., Fernández, R. E. & Maurelli, A. T. Chlamydia trachomatis transports NAD via the Npt1 ATP/ADP translocase. J. Bacteriol. 195, 3381–3386 (2013).
pmcid: 3719547
doi: 10.1128/JB.00433-13
Kanehisa, M. The KEGG database. Novartis Found. Symp. 247, 91–101, discussion 101–103, 119–128, 244–152 (2002).
Sayers, E. W. et al. Database resources of the national center for biotechnology information. Nucleic Acids Res. 50, D20–D26 (2022).
doi: 10.1093/nar/gkab1112
Thompson, J. D., Higgins, D. G. & Gibson, T. J. CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res. 22, 4673–4680 (1994).
pmcid: 308517
doi: 10.1093/nar/22.22.4673
Roskoski, R. in Methods in Enzymology, Vol. 99, 3–6 (Academic Press, 1983).
Orsburn, B. C. Proteome discoverer—a community enhanced data processing suite for protein informatics. Proteomes 9, 15 (2021).
pmcid: 8006021
doi: 10.3390/proteomes9010015
Kabsch, W. XDS. Acta Crystallogr. Sect. D., Biol. Crystallogr. 66, 125–132 (2010).
doi: 10.1107/S0907444909047337
Winter, G. xia2: an expert system for macromolecular crystallography data reduction. J. Appl. Crystallogr. 43, 186–190 (2010).
doi: 10.1107/S0021889809045701
Zwart, P. H. et al. Automated structure solution with the PHENIX suite. Methods Mol. Biol. 426, 419–435 (2008).
doi: 10.1007/978-1-60327-058-8_28
Emsley, P. & Cowtan, K. Coot: model-building tools for molecular graphics. Acta Crystallogr. Sect. D., Biol. Crystallogr. 60, 2126–2132 (2004).
doi: 10.1107/S0907444904019158
Murshudov, G. N., Vagin, A. A. & Dodson, E. J. Refinement of macromolecular structures by the maximum-likelihood method. Acta Crystallogr. Sect. D.-Biol. Crystallogr. 53, 240–255 (1997).
doi: 10.1107/S0907444996012255
Wallace, A. C., Laskowski, R. A. & Thornton, J. M. LIGPLOT: a program to generate schematic diagrams of protein-ligand interactions. Protein Eng. 8, 127–134 (1995).
doi: 10.1093/protein/8.2.127
Schuck, P., Perugini, M. A., Gonzales, N. R., Howlett, G. J. & Schubert, D. Size-distribution analysis of proteins by analytical ultracentrifugation: strategies and application to model systems. Biophys. J. 82, 1096–1111 (2002).
pmcid: 1301916
doi: 10.1016/S0006-3495(02)75469-6
Allen, W. J. et al. DOCK 6: Impact of new features and current docking performance. J. Comput. Chem. 36, 1132–1156 (2015).
pmcid: 4469538
doi: 10.1002/jcc.23905
Tamura, K., Stecher, G., Peterson, D., Filipski, A. & Kumar, S. MEGA6: molecular evolutionary genetics analysis version 6.0. Mol. Biol. Evol. 30, 2725–2729 (2013).
pmcid: 3840312
doi: 10.1093/molbev/mst197